scholarly journals Aggressiveness of Cancer-Care near the End-of-Life in Korea

2008 ◽  
Vol 38 (5) ◽  
pp. 381-386 ◽  
Author(s):  
B. Keam ◽  
D.-Y. Oh ◽  
S.-H. Lee ◽  
D.-W. Kim ◽  
M. R. Kim ◽  
...  
Keyword(s):  
2008 ◽  
Vol 26 (23) ◽  
pp. 3860-3866 ◽  
Author(s):  
Craig C. Earle ◽  
Mary Beth Landrum ◽  
Jeffrey M. Souza ◽  
Bridget A. Neville ◽  
Jane C. Weeks ◽  
...  

The purpose of this article is to review the literature and update analyses pertaining to the aggressiveness of cancer care near the end of life. Specifically, we will discuss trends and factors responsible for chemotherapy overuse very near death and underutilization of hospice services. Whether the concept of overly aggressive treatment represents a quality-of-care issue that is acceptable to all involved stakeholders is an open question.


2021 ◽  
Vol 163 ◽  
pp. S20-S21
Author(s):  
Amanda Khan ◽  
Hsien Seow ◽  
Rinku Sutradhar ◽  
Stuart Peacock ◽  
Kelvin Chan ◽  
...  

JAMA Oncology ◽  
2020 ◽  
Vol 6 (7) ◽  
pp. 1118
Author(s):  
Claire E. O’Hanlon ◽  
Anne M. Walling ◽  
Charlotta Lindvall

Author(s):  
Claire E. O'Hanlon ◽  
Charlotta Lindvall ◽  
Karleen F. Giannitrapani ◽  
Melissa Garrido ◽  
Christine Ritchie ◽  
...  

2020 ◽  
pp. bmjspcare-2020-002641
Author(s):  
Pierre Antoine Monier ◽  
Jan Chrusciel ◽  
Fiona Ecarnot ◽  
Eduardo Bruera ◽  
Stephane Sanchez ◽  
...  

ObjectivesPrevious studies have found an association between aggressive cancer care and lower quality end of life. Despite international recommendations, late or very late referral to palliative care seems frequent. This study aimed to evaluate the association between the duration of involvement of a palliative care team (PCT), and aggressive cancer care, and to identify factors associated with aggressive cancer care.MethodsWe performed an observational retrospective study in a single academic teaching hospital. In total, 561 inpatients with solid tumours or haematological malignancies were included. Patients followed by a PCT for at least 1 month before death were classified in the palliative care group. Aggressive cancer care was defined as: hospitalisations and/or a new line of chemotherapy within the last month of life, location of death, the use of chemotherapy in the last 2 weeks and hospice admissions within the last 3 days of life.ResultsAmong the 561 patients, 241 (43%) were referred to the PCT; 89 (16%) were followed by the PCT for a month or more before death. In the last 2 weeks of life, 124 (22%) patients received chemotherapy, 110 (20%) died in an acute care unit. At least one criterion of aggressive cancer care was found in 395 patients overall (71%). Aggressive cancer care was significantly less frequent when the PCT referral occurred >1 month before death (p<0.0001).ConclusionMore studies are needed to understand reasons for late referrals despite international recommendations encouraging integrative palliative care.Ethics approvalThe study was approved by the Grenoble Teaching Hospital ethics committee, and by the CNIL (French national commission for data privacy; Commission Nationale de l’Informatique et des Libertés) under the number 1987785 v 0. Due to ethical and legal restrictions, data are only available on request.


Introduction and overview of ethical guidance 170 End of life issues 172 Withdrawing and withholding treatment 176 Ethical and moral values affect all aspects of cancer care, including treatment, management of symptoms, end of life care and participation in research. With advancing medical technology and developing evidence-based practice, ethical issues in cancer care are increasingly complex....


JAMA Oncology ◽  
2020 ◽  
Vol 6 (7) ◽  
pp. 1119
Author(s):  
Lesley Anne Henson ◽  
Wei Gao

2019 ◽  
Vol 22 (7) ◽  
pp. 833-837
Author(s):  
Ana I. Tergas ◽  
Holly G. Prigerson ◽  
Megan J. Shen ◽  
Lisa M. Bates ◽  
Alfred I. Neugut ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document